Shandong Weigao Group Schedules Board Meeting for Annual Results and Dividend Decision

Shandong Weigao Group Medical Polymer Co ( (HK:1066) ) has provided an announcement.

Shandong Weigao Group Medical Polymer Co. announced that its board of directors will meet on March 26, 2025, to review and approve the audited annual results for the year ending December 31, 2024. The meeting will also consider the potential declaration of a final dividend, which could impact shareholder returns and reflect the company’s financial health.

More about Shandong Weigao Group Medical Polymer Co

Shandong Weigao Group Medical Polymer Co. operates in the medical industry, focusing on the production of medical devices and polymer products. The company is known for its comprehensive range of healthcare solutions and has a significant market presence in China.

YTD Price Performance: 13.21%

Average Trading Volume: 700

Technical Sentiment Consensus Rating: Buy

Current Market Cap: $2.93B

For an in-depth examination of 1066 stock, go to TipRanks’ Stock Analysis page.